1	IL-2-induced	il-2-induced	_	_	_	_	_	_	_
2	growth	growth	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	CD8+	cd8+	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cell	cell	_	_	_	_	_	_	_
7	prolymphocytic	prolymphocytic	_	_	_	_	_	_	_
8	leukemia	leukemia	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	mediated	mediate	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	induction	induction	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	receptor	receptor	_	_	_	_	_	_	_
17	alpha	alpha	_	_	_	_	_	_	_
18	expression	expression	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	interleukin-2	interleukin-2	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	its	its	_	_	_	_	_	_	_
10	receptor	receptor	_	_	_	_	_	_	_
11	on	on	_	_	_	_	_	_	_
12	normal	normal	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	induces	induce	_	_	_	_	_	_	_
16	nuclear	nuclear	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	factor	factor	_	_	_	_	_	_	_
21	kappaB	kappaB	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	activation	activation	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	IL-2	il-2	_	_	_	_	_	_	_
30	receptor	receptor	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	IL-2R	IL-2R	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	alpha	alpha	_	_	_	_	_	_	_
35	chain	chain	_	_	_	_	_	_	_
36	gene	gene	_	_	_	_	_	_	_
37	,	,	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	cell	cell	_	_	_	_	_	_	_
40	proliferation	proliferation	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	present	present	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	role	role	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	IL-2R	IL-2R	_	_	_	_	_	_	_
10	signaling	signaling	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	growth	growth	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	CD8+	cd8+	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cell	cell	_	_	_	_	_	_	_
18	prolymphocytic	prolymphocytic	_	_	_	_	_	_	_
19	leukemia	leukemia	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	T-PLL	T-PLL	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	has	have	_	_	_	_	_	_	_
25	been	be	_	_	_	_	_	_	_
26	investigated	investigate	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Flow	Flow	_	_	_	_	_	_	_
2	cytometry	cytometry	_	_	_	_	_	_	_
3	revealed	reveal	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	primary	primary	_	_	_	_	_	_	_
6	leukemia	leukemia	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	patient	patient	_	_	_	_	_	_	_
11	with	with	_	_	_	_	_	_	_
12	CD8+	cd8+	_	_	_	_	_	_	_
13	T-PLL	T-PLL	_	_	_	_	_	_	_
14	expressed	express	_	_	_	_	_	_	_
15	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	beta	beta	_	_	_	_	_	_	_
18	chains	chain	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	showed	show	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	proliferative	proliferative	_	_	_	_	_	_	_
26	response	response	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	an	an	_	_	_	_	_	_	_
29	increase	increase	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
32	expression	expression	_	_	_	_	_	_	_
33	on	on	_	_	_	_	_	_	_
34	culture	culture	_	_	_	_	_	_	_
35	with	with	_	_	_	_	_	_	_
36	exogeneous	exogeneous	_	_	_	_	_	_	_
37	IL-2	il-2	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	Northern	Northern	_	_	_	_	_	_	_
2	blot	blot	_	_	_	_	_	_	_
3	analysis	analysis	_	_	_	_	_	_	_
4	failed	fail	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	detect	detect	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	mRNA	mRNA	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	suggesting	suggest	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	IL-2	il-2	_	_	_	_	_	_	_
13	may	may	_	_	_	_	_	_	_
14	act	act	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	paracrine	paracrine	_	_	_	_	_	_	_
18	manner	manner	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	vivo	vivo	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility-shift	mobility-shift	_	_	_	_	_	_	_
3	assays	assay	_	_	_	_	_	_	_
4	revealed	reveal	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	recombinant	recombinant	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	increased	increase	_	_	_	_	_	_	_
9	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	activity	activity	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	extracts	extract	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	leukemia	leukemia	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	Northern	northern	_	_	_	_	_	_	_
22	blot	blot	_	_	_	_	_	_	_
23	analysis	analysis	_	_	_	_	_	_	_
24	showed	show	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	IL-2	il-2	_	_	_	_	_	_	_
27	increased	increase	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	abundance	abundance	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	mRNAs	mrna	_	_	_	_	_	_	_
32	encoding	encode	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
35	components	component	_	_	_	_	_	_	_
36	c-Rel	c-rel	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	KBF1	kbf1	_	_	_	_	_	_	_
39	in	in	_	_	_	_	_	_	_
40	these	these	_	_	_	_	_	_	_
41	cells	cell	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	analysis	analysis	_	_	_	_	_	_	_
4	demonstrated	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	markedly	markedly	_	_	_	_	_	_	_
8	increased	increase	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	number	number	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	low	low	_	_	_	_	_	_	_
13	affinity	affinity	_	_	_	_	_	_	_
14	IL-2Rs	il-2r	_	_	_	_	_	_	_
15	on	on	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	leukemia	leukemia	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	without	without	_	_	_	_	_	_	_
21	an	an	_	_	_	_	_	_	_
22	effect	effect	_	_	_	_	_	_	_
23	on	on	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	number	number	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	high-affinity	high-affinity	_	_	_	_	_	_	_
28	IL-2Rs	il-2r	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	IL-2	il-2	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	capable	capable	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	inducing	induce	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	primary	primary	_	_	_	_	_	_	_
17	CD8+	cd8+	_	_	_	_	_	_	_
18	T-PLL	t-pll	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	this	this	_	_	_	_	_	_	_
24	effect	effect	_	_	_	_	_	_	_
25	is	be	_	_	_	_	_	_	_
26	mediated	mediate	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	at	at	_	_	_	_	_	_	_
29	least	least	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	part	part	_	_	_	_	_	_	_
32	,	,	_	_	_	_	_	_	_
33	at	at	_	_	_	_	_	_	_
34	a	a	_	_	_	_	_	_	_
35	pretranslational	pretranslational	_	_	_	_	_	_	_
36	level	level	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

